1Peluso G, Nicolai R, Reda E, et al. Cancer and anticancer therapy-induced modifications on metabolism mediated by eamitine system. J Cell Physiol,2000,182 : 339-350.
4Kashfi K, Israel M, Sweatman TW, et al. Inhibition of mitochondrial camitine palmitoyltransferases by adriamycin and adriamycin analogues. Biochem Pharmacol, 1990, 40 : 1441-1448.
5Wouters KA, Ktemer LC, Miller TL, et al. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol,2005,131:561-578.
5Grossi F,Kubota K,Cappuzzo F,et al. Future scenarios for the treat- ment of advanced non-small cell lung cancer:focus on taxane-containing regimens[J]. Oncologist,2010,15(9) :1102-1112.
6Sacco G, Bigioni M, Lopez G, et al. ACE inhibition and protec tion from doxorubicin-induced cardiotoxicity in the rat[J]. Vas cul Pharmacol,2009,50(5) 166-170.
7Takayama K, Ishida K, Matsushita T, et al. SIRTI regulation of apoptosis of human chondrocytes[J]. Arthritis Rheum,2009,60 (9) :27:31-2740.
8Simunek T,Steda M, Popelova O. Anthracycline . induced cardiotox icity: overview or studies examining the roles of oxidative stress and free cellular iron'J]. Pharmacol Rep, 2009,61 (1) : 154-171.
9Michael J,Albert S, Alexandra K, et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signa- ling networks[J]. Cell, 2012,149(4) :780 794.
